Adsorption of a synthetic TLR7/8 ligand to aluminum oxyhydroxide for enhanced vaccine adjuvant activity: A formulation approach-Reference-Cited by-同舟云学术

Adsorption of a synthetic TLR7/8 ligand to aluminum oxyhydroxide for enhanced vaccine adjuvant activity: A formulation approach

Published:2016-12 Issue: Volume:244 Page:98-107
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Fox Christopher B.,Orr Mark T.,Van Hoeven Neal,Parker Sarah C.,Mikasa Traci J.T.,Phan Tony,Beebe Elyse A.,Nana Ghislain I.,Joshi Sharvari W,Tomai Mark A.,Elvecrog James,Fouts Timothy R.,Reed Steven G.

Funder

Bill and Melinda Gates Foundation

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference25 articles.

1. The antigenic value of toxoid precipitated by potassium alum;Glenny;J. Pathol. Bacteriol.,1926

2. Aluminum-containing adjuvants: properties, formulation, and use;Hem,2007

3. AS04, an aluminum salt- and TLR4 agonist-based adjuvant system, induces a transient localized innate immune response leading to enhanced adaptive immunity;Didierlaurent;J. Immunol.,2009

4. New generation adjuvants - from empricism to rational design;O'Hagan;Vaccine,2015

5. Enhanced antibody production in mice to the malaria antigen AMA1 by CPG 7909 requires physical association of CpG and antigen;Mullen;Vaccine,2007

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of 3M-052-AF with Alum adjuvant in HIV trimer vaccine induces human autologous neutralizing antibodies;Journal of Experimental Medicine;2024-09-05

2. Aluminum hydroxide and immunostimulatory glycolipid adjuvant combination for enhanced COVID-19 subunit vaccine immunogenicity;Vaccine;2024-08

3. Design and Synthesis of Polyphenolic Imidazo[4,5-c]quinoline Derivatives to Modulate Toll Like Receptor-7 Agonistic Activity and Adjuvanticity;ACS Pharmacology & Translational Science;2024-06-12

4. HIV BG505 SOSIP.664 trimer with 3M-052-AF/alum induces human autologous tier-2 neutralizing antibodies;2024-05-09

5. The scientific journey of a novel adjuvant (AS37) from bench to bedside;npj Vaccines;2024-02-08